Hepatitis B virus (HBV) and hepatitis C virus (HCV) are not only hepatotropic, but also lymphotropic viruses. Infections with these viruses induce chronic antigenicity and may stimulate clonal expansion of malignant B-cell neoplasms. Moreover, these viruses can proliferate in lymphatic structures and bone marrow. However, the relationship between lymphomas and HBV/HCV infections is not clear. In our region of the East Black Sea, Turkey (the city of Trabzon), we intended to demonstrate a relation of lymphoma and HBV/HCV infections with a case-controlled study.
Methods
A total of 109 patients diagnosed with lymphoma between 2002–2005 in the Black Sea Technical University Hospital was investigated. Seventy-one patients had a high-grade and 38 patients a low-grade lymphoma. Hepatitis B surface antigen (HBsAg) and anti-HCV antibodies (anti-HCV Ab) were screened. The control group consisted of patients (n = 551) from other departments with diagnoses other than lymphoma.
Results
HBsAg was 3.7% and anti-HCV Ab positivity was 2.8% in lymphoma patients, compared with control of 5.3%, 5.1%, respectively. There was no statistically significant difference between two groups (P = 0.7, OR = 0.69, 95% CI, 0.20–2.10; P = 0.4, OR = 0.53, 95% CI, 0.13–1.86, respectively).
Conclusion
Our findings suggest that the incidence of HBV and HCV infections in lymphoma patients is no different than that of nonlymphoma patients. Therefore, no direct correlation can be deduced between lymphoma and HBV-HCV infections in our East Black Sea region of Turkey.
GaidanoG., Dalla-FaveraR.: Pathobiology of non-Hodgkin's lymphomas. In: Hematology basic principles and practice, Fourth edition, pp 1307–1324, Elsevier Inc., Philadelphia, 2005.
2.
MatsuoK., HamajimaN., HiroseK., InoueM., TakezakiT., KuroishiT., TajimaK.: Alcohol, smoking, and dietary status and susceptibility to malignant lymphoma in Japan: results of a hospital-based case-control study at Aichi Cancer Center. Jpn J Cancer Res, 92: 1011–1017, 2001.
3.
TanakaK., HirohataT., KogaS., SugimachiK., KanematsuT., OhryohjiF., NawataH., IshibashiH., MaedaY., KiyokawaH.: Hepatitis C and hepatitis B in the etiology of hepatocellular carcinoma in the Japanese population. Cancer Res, 51: 2842–2847, 1991.
4.
LiangR.H., LokA.S., LaiC.L., ChanT.K., ToddD., ChiuE.K.: Hepatitis B infection in patients with lymphomas. Hematol Oncol, 8: 261–270, 1990.
NietersA., KallinowskiB., BrennanP., OttM., MaynadieM., BenaventeY., ForetovaL., CoccoP.L., StainesA., VornanenM., WhitbyD., BoffettaP., BeckerN., De SanjoseS.: Hepatitis C and risk of lymphoma: results of the European multicenter case-control study EPILYMPH. Gastroenterology, 131: 1879–1886, 2006.
7.
MarcucciF., MeleA., SpadaE., CandidoA., BiancoE., PulsoniA., ChionneP., MadonnaE., CotichiniR., BarbuiA., De RenzoA., DoreF., IannittoE., LisoV., MartinoB., MontanaroM., PaganoL., MustoP., RapicettaM.: High prevalence of hepatitis B virus infection in B-cell non-Hodgkin's lymphoma. Haematologica, 91: 554–557, 2006.
8.
IwataH., MatsuoK., TakeuchiK., KishiY., MurashigeN., KamiM.: High incidences of malignant lymphoma in patients infected with hepatitis B or hepatitis C virus. Haematologica, 89: 368–370, 2004.
9.
MeleA., PulsoniA., BiancoE., MustoP., SzkloA., SanpaoloM.G., IannittoE., De RenzoA., MartinoB., LisoV., AndrizziC., PusterlaS., DoreF., MarescaM., RapicettaM., MarcucciF., MandelliF., FranceschiS.: Hepatitis C virus and B-cell non-Hodgkin lymphomas: an Italian multicenter case-control study. Blood, 102: 996–999, 2003.
10.
ImaiY., OhsawaM., TanakaH., TamuraS., SugawaraH., KuyamaJ., FukudaK., YonezawaT., MatsuzawaY.: High prevalence of HCV infection in patients with B-cell non-Hodgkin's lymphoma: comparison with birth cohort- and sex-matched blood donors in a Japanese population. Hepatology, 37: 719, 2003.
11.
TakeshitaM., SakaiH., OkamuraS., HigakiK., OshiroY., UikeN., YamamotoI., ShimamatsuK., MuranakaT.: Prevalence of hepatitis C virus infection in cases of B-cell lymphoma in Japan. Histopathology, 48: 189–198, 2006.
12.
Dal MasoL., FranceschiS.: Hepatitis C virus and risk of lymphoma and other lymphoid neoplasms: a meta-analysis of epidemiologic studies. Cancer Epidemiol Biomarkers Prev, 15: 2078–2085, 2006.
13.
MatsuoK., KusanoA., SugumarA., NakamuraS., TajimaK., MuellerN.E.: Effect of hepatitis C virus infection on the risk of non-Hodgkin's lymphoma: a meta-analysis of epidemiological studies. Cancer Sci, 95: 745–752, 2004.
14.
KimJ.H., BangY.J., ParkB.J., YooT., KimC.W., KimT.Y., HeoD.S., LeeH.S., KimN.K.: Hepatitis B virus infection and B-cell non-Hodgkin's lymphoma in a hepatitis B endemic area: a case-control study. Jpn J Cancer Res, 93: 471–477, 2002.
15.
KuniyoshiM., NakamutaM., SakaiH., EnjojiM., KinukawaN., KotohK., FukutomiM., YokotaM., NishiH., IwamotoH., UikeN., NishimuraJ., InabaS., MaedaY., NawataH., MutaK.: Prevalence of hepatitis B or C virus infections in patients with non-Hodgkin's lymphoma. J Gastroenterol Hepatol, 16: 215–219, 2001.
16.
NegriE., LittleD., BoiocchiM., La VecchiaC., FranceschiS.: B-cell non-Hodgkin's lymphoma and hepatitis C virus infection: a systematic review. Int J Cancer, 111: 1–8, 2004.
17.
CucuianuA., PatiuM., DumaM., BasarabC., SoritauO., BojanA., VasilacheA., MatesM., PetrovL.: Hepatitis B and C virus infection in Romanian non-Hodgkin's lymphoma patients. Br J Haematol, 107: 353–356, 1999.
18.
MazzaroC., TirelliU., PozzatoG.: Hepatitis C virus and non-Hodgkin's lymphoma 10 years later. Dig Liver Dis, 37: 219–226, 2005.
RosaD., SalettiG., PozzatoG., AbrignaniS.: HCV can activate B cells via CD81 engagement: a molecular mechanism for B cell autoreactivity and crioglobulinemia in HCV infection. Hepatology, 34: 252, 2001.
21.
IvanovskiM., SilvestriF., PozzatoG., AnandS., MazzaroC., BurroneO.R., EfremovD.G.: Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas. Blood, 91: 2433–2442, 1998.
22.
De RosaG., GobboM.L., De RenzoA., NotaroR., GarofaloS., GrimaldiM., ApuzzoA., ChiurazziF., PicardiM., MatarazzoM., RotoliB.: High prevalence of hepatitis C virus infection in patients with B-cell lymphoproliferative disorders in Italy. Am J Hematol, 55: 77–82, 1997.
23.
TakaiS., TsurumiH., AndoK., KasaharaS., SawadaM., YamadaT., HaraT., FukunoK., TakahashiT., OyamaM., OnishiH., TomitaE., TakamiT., ImawariM., MoriwakiH.: Prevalence of hepatitis B and C virus infection in haematological malignancies and liver injury following chemotherapy. Eur J Haematol, 74: 158–165, 2005.
24.
KumagaiK., TakagiT., NakamuraS., SawadaU., KuraY., KodamaF., ShimanoS., KudohI., NakamuraH., SawadaK., OhnoshiT.: Hepatitis B virus carriers in the treatment of malignant lymphoma: an epidemiological study in Japan. Ann Oncol, 1: 107–109, 1997.
25.
TalaminiR., MontellaM., CrovattoM., Dal MasoL., CrispoA., NegriE., SpinaM., PintoA., CarboneA., FranceschiS.: Non-Hodgkin's lymphoma and hepatitis C virus: a case-control study from northern and southern Italy. Int J Cancer, 110: 380–385, 2004.
26.
EngelsE.A., ChatterjeeN., CerhanJ.R., DavisS., CozenW., SeversonR.K., WhitbyD., ColtJ.S., HartgeP.: Hepatitis C virus infection and non-Hodgkin lymphoma: results of the NCI-SEER multi-center case-control study. Int J Cancer, 111: 76–80, 2004.
27.
de SanjoseS., NietersA., GoedertJ.J., Domingo-DomenechE., Fernandez de SevillaA., BoschR., HerreraP., DomingoA., PetitJ., BoschX., KallinowskiB.: Role of hepatitis C virus infection in malignant lymphoma in Spain. Int J Cancer, 111: 81–85, 2004.
28.
MarkovicS., DrozinaG., VovkM., Fidler-JenkoM.: Reactivation of hepatitis B but not hepatitis C in patients with malignant lymphoma and immunosuppressive therapy. A prospective study in 305 patients. Hepatogastroenterology, 46: 2925–2930, 1999.
29.
DubergA.S., NordstromM., TornerA., ReichardO., StraussR., JanzonR., BackE., EkdahlK.: Non-Hodgkin's lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection. Hepatology, 41: 652–659, 2005.
30.
MortonL.M., EngelsE.A., HolfordT.R., LeadererB., ZhangY., ZahmS.H., BoyleP., ZhangB., FlynnS., TalliniG., OwensP.H., ZhengT.: Hepatitis C virus and risk of non-Hodgkin lymphoma: a population-based case-control study among Connecticut women. Cancer Epidemiol Biomarkers Prev, 13: 425–430, 2004.
31.
TimuragaogluA., ColakD., OgüncD., KaradoganI., UndarL.: Hepatitis C virus association with non-Hodgkin's lymphoma. Hematologia, 29: 301–304, 1999.
32.
AricanA., SengezerT., BozdayiM., BozkayaH., UcgulE., DincolD., UzunalimogluO.: Prevalence of hepatitis-G virus and hepatitis-C virus infection in patients with non-Hodgkin's lymphoma. Med Oncol, 17: 123–126, 2000.
33.
PaydasS., KilicB., SahinB., BugdayciR.: Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders in Southern Turkey. Br J Cancer, 80: 1303–1305, 1999.
34.
KayaH., PolatM.F., ErdemF., GundogduM.: Prevalence of hepatitis C virus and hepatitis G virus in patients with non-Hodgkin's lymphoma. Clin Lab Haematol, 24: 107–110, 2002.
35.
IsikdoganA., AyyildizO., DursunM., TiftikN., BatunS., MuftuogluE.: Hepatitis C virus in patients with non-Hodgkin's lymphoma in southeastern Anatolia region of Turkey: a prospective case-control study of 119 patients. Leuk Lymphoma, 44: 1745–1747, 2003.
36.
PaydasS., KilicB., YavuzS., DiselU., TanriverdiK., SahinB., BurgutR.: Anti-HCV and HCV-RNA prevalence and clinical correlations in cases with non-Hodgkin's lymphoma. Am J Hematol, 74: 89–93, 2003.
WeinerS.M., BergT., BertholdH., WeberS., PetersT., BlumH.E., HopfU., PeterH.H.: A clinical and virological study of hepatitis C virus-related cryoglobulinemia in Germany. J Hepatol, 29: 375–384, 1998.
39.
DurmusG., EremC., SönmezM., MocanZ., TelatarM., YanarG.C.: Trabzon Bölgesinde Hepatit B virüs enfeksiyonu sero-epidemiyolojisi. Yeni Tip Derg, 13: 228–231, 1996.
40.
AydinF., CanyilmazD., CihanyurduD., CubukcuK., ErtürkM.: KTÜ Farabi hastanesi kan merkezine başvuran 30190 kan donöründe HBsAg, HCV, HIV ve sifilis seropozitifliği. VIII. Türk Klinik Mikrobiyoloji ve Enfeksiyon Hastaliklari Kongresi. Kongre Kitabi, s445, 1997.
